These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35746614)

  • 21. Sodium Copper Chlorophyllin Is Highly Effective against Enterovirus (EV) A71 Infection by Blocking Its Entry into the Host Cell.
    Liu Z; Xia S; Wang X; Lan Q; Li P; Xu W; Wang Q; Lu L; Jiang S
    ACS Infect Dis; 2020 May; 6(5):882-890. PubMed ID: 32233455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo.
    Yang Y; Zhang L; Fan X; Qin C; Liu J
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2209-11. PubMed ID: 22342145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral activity of Mulberroside C against enterovirus A71 in vitro and in vivo.
    Cao Y; Lei E; Li L; Ren J; He X; Yang J; Wang S
    Eur J Pharmacol; 2021 Sep; 906():174204. PubMed ID: 34051220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antivirals and vaccines for Enterovirus A71.
    Lin JY; Kung YA; Shih SR
    J Biomed Sci; 2019 Sep; 26(1):65. PubMed ID: 31481071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the proteostasis network during enterovirus infection: A feedforward mechanism for EV-A71 and EV-D68.
    Jheng JR; Chen YS; Horng JT
    Antiviral Res; 2021 Apr; 188():105019. PubMed ID: 33484748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RdRp inhibitors and COVID-19: Is molnupiravir a good option?
    Hashemian SMR; Pourhanifeh MH; Hamblin MR; Shahrzad MK; Mirzaei H
    Biomed Pharmacother; 2022 Feb; 146():112517. PubMed ID: 34902743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study.
    Messacar K; Spence-Davizon E; Osborne C; Press C; Schreiner TL; Martin J; Messer R; Maloney J; Burakoff A; Barnes M; Rogers S; Lopez AS; Routh J; Gerber SI; Oberste MS; Nix WA; Abzug MJ; Tyler KL; Herlihy R; Dominguez SR
    Lancet Infect Dis; 2020 Feb; 20(2):230-239. PubMed ID: 31859216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19.
    Painter GR; Natchus MG; Cohen O; Holman W; Painter WP
    Curr Opin Virol; 2021 Oct; 50():17-22. PubMed ID: 34271264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19.
    Imran M; Kumar Arora M; Asdaq SMB; Khan SA; Alaqel SI; Alshammari MK; Alshehri MM; Alshrari AS; Mateq Ali A; Al-Shammeri AM; Alhazmi BD; Harshan AA; Alam MT; Abida
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validating Enterovirus D68-2A
    Musharrafieh R; Ma C; Zhang J; Hu Y; Diesing JM; Marty MT; Wang J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo.
    Zeng S; Meng X; Huang Q; Lei N; Zeng L; Jiang X; Guo X
    Int J Antimicrob Agents; 2019 Apr; 53(4):362-369. PubMed ID: 30599241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroepidemiological and phylogenetic characterization of neurotropic enteroviruses in Ireland, 2005-2014.
    Guerra JA; Waters A; Kelly A; Morley U; O'Reilly P; O'Kelly E; Dean J; Cunney R; O'Lorcain P; Cotter S; Connell J; O'Gorman J; Hall WW; Carr M; De Gascun CF
    J Med Virol; 2017 Sep; 89(9):1550-1558. PubMed ID: 28071799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated first-in-human clinical trial of EIDD-2801/MK-4482 (molnupiravir), a ribonucleoside analog with potent antiviral activity against SARS-CoV-2.
    Holman W; Holman W; McIntosh S; Painter W; Painter G; Bush J; Cohen O
    Trials; 2021 Aug; 22(1):561. PubMed ID: 34425873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ginsenoside Rb1 is an immune-stimulatory agent with antiviral activity against enterovirus 71.
    Kang N; Gao H; He L; Liu Y; Fan H; Xu Q; Yang S
    J Ethnopharmacol; 2021 Feb; 266():113401. PubMed ID: 32980486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antiviral activity of medicinal mushroom Ganoderma neo-japonicum Imazeki against enteroviruses that caused hand, foot and mouth disease.
    Ang WX; Sarasvathy S; Kuppusamy UR; Sabaratnam V; Tan SH; Wong KT; Perera D; Ong KC
    Trop Biomed; 2021 Sep; 38(3):239-247. PubMed ID: 34362866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological Characterization of the Mechanism of Action of
    Ma C; Hu Y; Zhang J; Wang J
    ACS Infect Dis; 2020 Aug; 6(8):2260-2270. PubMed ID: 32692536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via Inhibition of Viral 2A Protease.
    Wang CY; Huang AC; Hour MJ; Huang SH; Kung SH; Chen CH; Chen IC; Chang YS; Lien JC; Lin CW
    Viruses; 2015 Jun; 7(6):3155-71. PubMed ID: 26090728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral activity of silymarin in comparison with baicalein against EV-A71.
    Lalani SS; Anasir MI; Poh CL
    BMC Complement Med Ther; 2020 Mar; 20(1):97. PubMed ID: 32293397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of 14S-(2'-chloro-4'-nitrophenoxy)-8R/S,17-epoxy andrographolide as EV-A71 infection inhibitor.
    Dai K; Tan JK; Qian W; Lee RCH; Hann Chu JJ; Zhou GC
    Biochem Pharmacol; 2021 Dec; 194():114820. PubMed ID: 34748818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molnupiravir: A lethal mutagenic drug against rapidly mutating severe acute respiratory syndrome coronavirus 2-A narrative review.
    Masyeni S; Iqhrammullah M; Frediansyah A; Nainu F; Tallei T; Emran TB; Ophinni Y; Dhama K; Harapan H
    J Med Virol; 2022 Jul; 94(7):3006-3016. PubMed ID: 35315098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.